Published in TB and Outbreaks Week, March 12th, 2002
According to the company, the skin test will be the world's first diagnostic that can distinguish between active infectious TB, latent TB and prior TB vaccination. The Transdermal Patch is configured as a simple Band-Aid applied to the forearm that delivers a soluble TB protein directly to the skin, a distinct advantage over the current nonspecific Mantoux skin test that must be administered by a needle and syringe.
The Transdermal Patch distinguishes active TB disease from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.